These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 24790265

  • 21. Effect of almitrine bismesylate on breathing pattern during hypoxia/hypercapnia in rats and ferrets.
    Austin CA, Wach RA, Bee D, Finlay M, Emery CJ, Suggett AJ, Barer GR.
    Clin Exp Pharmacol Physiol; 1987; 14(11-12):837-50. PubMed ID: 2896080
    [Abstract] [Full Text] [Related]

  • 22. Dexmedetomidine: pediatric pharmacology, clinical uses and safety.
    Su F, Hammer GB.
    Expert Opin Drug Saf; 2011 Jan; 10(1):55-66. PubMed ID: 20718689
    [Abstract] [Full Text] [Related]

  • 23. Ventilatory behavior and metabolism in two strains of obese rats.
    Strohl KP, Thomas AJ.
    Respir Physiol; 2001 Jan; 124(2):85-93. PubMed ID: 11164200
    [Abstract] [Full Text] [Related]

  • 24. Effect of changing body temperature on the ventilatory and metabolic responses of lean and obese Zucker rats.
    Maskrey M, Megirian D, Farkas GA.
    Am J Physiol; 1998 Aug; 275(2):R531-40. PubMed ID: 9688690
    [Abstract] [Full Text] [Related]

  • 25. Hippocampal adult neurogenesis is enhanced by chronic eszopiclone treatment in rats.
    Methippara M, Bashir T, Suntsova N, Szymusiak R, McGinty D.
    J Sleep Res; 2010 Sep; 19(3):384-93. PubMed ID: 20408925
    [Abstract] [Full Text] [Related]

  • 26. GABAergic modulation of ventilation and peak oxygen consumption in obese Zucker rats.
    Lee SD, Nakano H, Farkas GA.
    J Appl Physiol (1985); 2001 May; 90(5):1707-13. PubMed ID: 11299259
    [Abstract] [Full Text] [Related]

  • 27. Sedative but not analgesic alpha2 agonist tolerance is blocked by NMDA receptor and nitric oxide synthase inhibitors.
    Davies MF, Reid K, Guo TZ, Agashe GS, Amin YK, Maze M.
    Anesthesiology; 2001 Jul; 95(1):184-91. PubMed ID: 11465557
    [Abstract] [Full Text] [Related]

  • 28. Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators.
    Gotter AL, Garson SL, Stevens J, Munden RL, Fox SV, Tannenbaum PL, Yao L, Kuduk SD, McDonald T, Uslaner JM, Tye SJ, Coleman PJ, Winrow CJ, Renger JJ.
    BMC Neurosci; 2014 Sep 22; 15():109. PubMed ID: 25242351
    [Abstract] [Full Text] [Related]

  • 29. The Effects of Short-Term Propofol and Dexmedetomidine on Lung Mechanics, Histology, and Biological Markers in Experimental Obesity.
    Heil LB, Santos CL, Santos RS, Samary CS, Cavalcanti VC, Araújo MM, Poggio H, Maia Lde A, Trevenzoli IH, Pelosi P, Fernandes FC, Villela NR, Silva PL, Rocco PR.
    Anesth Analg; 2016 Apr 22; 122(4):1015-23. PubMed ID: 26720616
    [Abstract] [Full Text] [Related]

  • 30. Effects of eszopiclone and zolpidem on sleep-wake behavior, anxiety-like behavior and contextual memory in rats.
    Huang MP, Radadia K, Macone BW, Auerbach SH, Datta S.
    Behav Brain Res; 2010 Jun 26; 210(1):54-66. PubMed ID: 20153782
    [Abstract] [Full Text] [Related]

  • 31. Effect of dexmedetomidine on cardiorespiratory regulation in spontaneously breathing adult rats.
    Kitajima Y, Hashizume NS, Saiki C, Ide R, Imai T.
    PLoS One; 2022 Jun 26; 17(1):e0262263. PubMed ID: 35030204
    [Abstract] [Full Text] [Related]

  • 32. Sedation with Dexmedetomidine or Propofol Impairs Hypoxic Control of Breathing in Healthy Male Volunteers: A Nonblinded, Randomized Crossover Study.
    Lodenius Å, Ebberyd A, Hårdemark Cedborg A, Hagel E, Mkrtchian S, Christensson E, Ullman J, Scheinin M, Eriksson LI, Jonsson Fagerlund M.
    Anesthesiology; 2016 Oct 26; 125(4):700-15. PubMed ID: 27483127
    [Abstract] [Full Text] [Related]

  • 33. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
    Hayashi Y, Guo TZ, Maze M.
    Anesthesiology; 1995 Apr 26; 82(4):954-62. PubMed ID: 7717568
    [Abstract] [Full Text] [Related]

  • 34. Dexmedetomidine and clonidine: from second- to first-line sedative agents in the critical care setting?
    Pichot C, Ghignone M, Quintin L.
    J Intensive Care Med; 2012 Apr 26; 27(4):219-37. PubMed ID: 21525113
    [Abstract] [Full Text] [Related]

  • 35. Eszopiclone prevents excitotoxicity and neurodegeneration in the hippocampus induced by experimental apnea.
    Fung SJ, Xi MC, Zhang JH, Yamuy J, Sampogna S, Tsai KL, Lim V, Morales FR, Chase MH.
    Sleep; 2009 Dec 26; 32(12):1593-601. PubMed ID: 20041595
    [Abstract] [Full Text] [Related]

  • 36. [Dexmedetomidine. Pharmacokinetics and pharmacodynamics].
    Ihmsen H, Saari TI.
    Anaesthesist; 2012 Dec 26; 61(12):1059-66. PubMed ID: 23223843
    [Abstract] [Full Text] [Related]

  • 37. Eszopiclone: a review of its use in the treatment of insomnia.
    Hair PI, McCormack PL, Curran MP.
    Drugs; 2008 Dec 26; 68(10):1415-34. PubMed ID: 18578559
    [Abstract] [Full Text] [Related]

  • 38. Eszopiclone and fluoxetine enhance the survival of newborn neurons in the adult rat hippocampus.
    Su XW, Li XY, Banasr M, Duman RS.
    Int J Neuropsychopharmacol; 2009 Nov 26; 12(10):1421-8. PubMed ID: 19775501
    [Abstract] [Full Text] [Related]

  • 39. Dexmedetomidine: new insights.
    Mantz J, Josserand J, Hamada S.
    Eur J Anaesthesiol; 2011 Jan 26; 28(1):3-6. PubMed ID: 20881501
    [Abstract] [Full Text] [Related]

  • 40. Eszopiclone: an update on its use in insomnia.
    Owen RT.
    Drugs Today (Barc); 2011 Apr 26; 47(4):263-75. PubMed ID: 21573250
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.